Stability indicating HPLC-DAD method for analysis of Ketorolac binary and ternary mixtures in eye drops: Quantitative analysis in rabbit aqueous humor

•HPLC-DAD method for assay of Ketorolac tromethamine binary and ternary mixtures.•Analysis in-vitro was stability indicating in presence of possible degradations.•Internal standard method was used for assay in rabbit aqueous humor.•Validation according to FDA regulation for in-vivo and ICH for in-vi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2017-11, Vol.1068-1069, p.218-225
Hauptverfasser: El Yazbi, Fawzy A., Hassan, Ekram M., Khamis, Essam F., Ragab, Marwa A.A., Hamdy, Mohamed M.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•HPLC-DAD method for assay of Ketorolac tromethamine binary and ternary mixtures.•Analysis in-vitro was stability indicating in presence of possible degradations.•Internal standard method was used for assay in rabbit aqueous humor.•Validation according to FDA regulation for in-vivo and ICH for in-vitro assays.•Assay of drugs with degradations, eye drops excipients and biological interference. Ketorolac tromethamine (KTC) with phenylephrine hydrochloride (PHE) binary mixture (mixture 1) and their ternary mixture with chlorpheniramine maleate (CPM) (mixture 2) were analyzed using a validated HPLC-DAD method. The developed method was suitable for the in vitro as well as quantitative analysis of the targeted mixtures in rabbit aqueous humor. The analysis in dosage form (eye drops) was a stability indicating one at which drugs were separated from possible degradation products arising from different stress conditions (in vitro analysis). For analysis in aqueous humor, Guaifenesin (GUF) was used as internal standard and the method was validated according to FDA regulation for analysis in biological fluids. Agilent 5 HC-C18(2) 150×4.6mm was used as stationary phase with a gradient eluting solvent of 20mM phosphate buffer pH 4.6 containing 0.2% triethylamine and acetonitrile. The drugs were resolved with retention times of 2.41, 5.26, 7.92 and 9.64min for PHE, GUF, KTC and CPM, respectively. The method was sensitive and selective to analyze simultaneously the three drugs in presence of possible forced degradation products and dosage form excipients (in vitro analysis) and also with the internal standard, in presence of aqueous humor interferences (analysis in biological fluid), at a single wavelength (261nm). No extraction procedure was required for analysis in aqueous humor. The simplicity of the method emphasizes its capability to analyze the drugs in vivo (in rabbit aqueous humor) and in vitro (in pharmaceutical formulations).
ISSN:1570-0232
1873-376X
DOI:10.1016/j.jchromb.2017.10.024